Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Assessing EGFR mutations

Antonio Marchetti, Lara Felicioni, Fiamma Buttitta

    The New England Journal of Medicine
    |February 3, 2006
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    An Interactive Digital Dashboard for Patient Monitoring and Management in a Continuity of Care Centre: Development and Preliminary Usability Evaluation Study.

    JMIR formative research·2026
    Same author

    Transforming Hospital Data into Real-World Evidence for Clinical Research: Insights into a Scalable Framework at Fondazione Policlinico Gemelli Hospital.

    Studies in health technology and informatics·2026
    Same author

    Standardizing the pathologic assessment of HER2-(ultra)low breast cancer: insights from a national Italian project.

    Pathologica·2026
    Same author

    The RAS testing in real world management of metastatic colorectal cancer: The results of Italian Laboratories Survey.

    Critical reviews in oncology/hematology·2026
    Same author

    Liquid biopsy in Oncology: Results of a Delphi consensus study endorsed by the AIOM-SIAPEC/IAP-SIBioC-SIF Italian scientific societies.

    The journal of liquid biopsy·2026
    Same author

    Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker.

    Molecular oncology·2025